Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 5, 2006
Patent Application Number
10734857
Date Filed
December 12, 2003
Patent Primary Examiner
Patent abstract
Novel combined vaccine compositions are provided, comprising a herpes simplex virus (HSV) antigen and a HPV antigen and optionally in addition one or more of the following: an EBV antigen, a hepatitis A antigen or inactivated attenuated virus, a hepatitis B viral antigen, a VZV antigen, a HCMV antigen, a Toxoplasma gondii antigen. The vaccine compositions are formulated with an adjuvant which is a preferential stimulator of TH1 cell response such as 3D-MPL and QS21.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
